Equity Analysis

Quarterly Results

    Wanbury Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    524212
    INE107F01022
    8.4982974
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    WANBURY
    17.89
    543.74
    EPS(TTM)
    Face Value()
    Div & Yield %:
    9.28
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsMar 2024Dec 2023Sep 2023
Gross Sales139.41145.50144.46
Other Operating Income0.000.000.00
Other Income 0.930.690.76
Total Income140.33146.19145.22
Total Expenditure 121.24124.35127.12
PBIDT19.0921.8418.10
Interest 7.468.267.67
PBDT11.6313.5810.43
Depreciation3.283.323.24
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.27-0.02-0.18
Reported Profit After Tax8.0810.277.36
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item8.0810.277.36
EPS (Unit Curr.)2.473.142.25
EPS (Adj) (Unit Curr.)2.473.142.25
Calculated EPS (Unit Curr.)2.473.142.25
Calculated EPS (Adj) (Unit Curr.)2.473.142.25
Calculated EPS (Ann.) (Unit Curr.)9.8712.559.00
Calculated EPS (Adj) (Ann.) (Unit Curr.)9.8712.559.00
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity32.7532.7532.74
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)13.6915.0112.53
PBDTM(%)8.349.337.22
PATM(%)5.807.065.09
Dividend Per Share(Rs)0.000.000.00
Diluted EPS2.473.142.25